$64.46 0.61 (+0.96%)
11/6/2009 4:00 PM

Chattem, Inc. (CHTT)

CAPS Rating: 3 out of 5

Marketer and manufacturer of a broad portfolio of branded over-the-counter healthcare products, toiletries and dietary supplements including such categories as topical analgesics, medicated skin care products, medicated dandruff shampoos and conditioners.

Current Price $64.46 Mkt Cap $1.23B
Open $63.50 P/E Ratio 14.61
Prev. Close $63.85 Div. (Yield) N/A (N/A)
Daily Range $62.91 - $64.47 Volume 126,235
52-Wk Range $50.10 - $74.12 Avg. Daily Vol. 259,000

CHTT News and Commentary

Caps

How do you think CHTT will perform vs the S&P 500?

Add Stock to Watchlist

All Members

161 Outperform
14 Underperform
 

All-Star Members

46 Outperform
6 Underperform
 

Wall Street

10 Outperform
1 Underperform
 

Top CHTT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

ongkaili (< 20)
Submitted July 09, 2008

its gonna power its way up on earnings.1) ice hot patch dmg over rated; its only the patch! they have other mediums of application!2) very high debt; but that's good debt not bad debt, but i dont deny that it would have a downwards pressure on the… More

MNNice (< 20)
Submitted February 08, 2009

CHTT is being sued by Lectec corp for patent infringement of Lectec's transdermal patch technology. On Friday, Feb 6th, Lectec filed a preliminary injunction against the defendants. The motion is very strong. Lectec has two re-examined patents...no… More

CHTT VS S&P 500 (SPY)

Fools bullish on CHTT are also bullish on:

Fools bearish on CHTT are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about CHTT.

Recs

0
Member Avatar wooderino (89.64) Submitted: 10/27/2009 12:15:50 PM : Outperform Start Price: $64.67 CHTT Score: -0.37

Showed up on a screen for solid 5 year growth with low debt, cash on hand and still at attractive P/E ratios.

Recs

0
Member Avatar 00100 (95.30) Submitted: 7/8/2009 2:33:08 PM : Outperform Start Price: $62.72 CHTT Score: -19.91

Upthumb. Good cash flow but high debt. Steady growth.

Recs

1
Member Avatar MNNice (< 20) Submitted: 2/8/2009 10:03:23 AM : Underperform Start Price: $69.00 CHTT Score: +31.95

CHTT is being sued by Lectec corp for patent infringement of Lectec's transdermal patch technology. On Friday, Feb 6th, Lectec filed a preliminary injunction against the defendants. The motion is very strong. Lectec has two re-examined patents...no re-examined patent has ever been found invalid in a court of law. A top legal firm, Radar, and the case is being tried in Texarcana, the rocket-docket that's also very plaintiff friendly in patent infringement lawsuits. Lectec has an expert witness, Dr. Guy. Many other witnesses and documents will come to light.

Leaderboard

Find the members with the highest scoring picks in CHTT.

Score Leader

jimbono

jimbono (89.63) Score: +106.95

The Score Leader is the member with the highest score across all their picks in CHTT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
jimbono 89.63 9/15/2006 Outperform 1Y $33.27 +93.75% -13.21% +106.95
ValRae < 20 9/27/2006 Outperform 1Y $34.89 +84.75% -14.86% +99.61
jreeser 88.31 10/5/2006 Outperform 1Y $35.68 +80.66% -15.70% +96.37
kincaidaldi 74.69 9/23/2006 Outperform NS $35.24 +82.92% -13.36% +96.28
jjcosgrow < 20 10/19/2006 Outperform 5Y $42.72 +50.89% -16.60% +67.49
hodedofome < 20 10/9/2006 Outperform 3W $43.09 +49.59% -15.68% +65.28
littlezook < 20 10/17/2006 Outperform 1Y $43.63 +47.74% -16.13% +63.87
johntdang 88.41 11/6/2006 Outperform 3Y $44.41 +45.15% -17.85% +63.00
kumiawan 83.69 10/9/2006 Outperform NS $43.81 +47.14% -15.71% +62.85
guyg5781 < 20 10/11/2006 Outperform 1Y $44.13 +46.07% -15.67% +61.74

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRBCCapMkts 81.74 4/22/2009 Outperform NS $57.00 +13.09% +26.42% -13.34
TrackOppenheimer 26.63 2/11/2009 Outperform NS $64.86 -0.62% +30.64% -31.26
TrackJPMorgan 78.71 7/28/2008 Outperform NS $65.77 -1.99% -11.92% +9.93
TrackTobinSmith < 20 4/4/2008 Outperform 1Y $66.07 -2.44% -18.88% +16.45
TrackStanfordRes 80.42 1/29/2008 Outperform NS $73.80 -12.66% -17.72% +5.07
TrackJimCramer < 20 1/7/2008 Outperform 3W $74.01 -12.90% -20.93% +8.02
TrackWachovia 35.10 11/12/2007 Outperform NS $68.00 -5.21% -22.71% +17.50
TrackJefferies 75.83 10/18/2007 Outperform NS $72.56 -12.10% -42.31% +30.21 7/8/2009 @ $63.78
TrackSoros 65.62 9/30/2007 Outperform NS $70.52 -8.59% -26.44% +17.84 1 Comment
TrackJimCramer < 20 9/27/2007 Underperform 3W $71.45 +3.58% -7.77% -11.36 1/7/2008 @ $74.01
TrackCLKing < 20 2/13/2007 Underperform NS $52.63 +17.44% -11.45% -28.89 7/10/2008 @ $61.81
TrackBreanMurray 89.84 2/12/2007 Underperform NS $53.90 +19.59% -20.88% -40.47
TrackAvondale 91.47 1/4/2007 Outperform NS $50.49 +27.67% -19.49% +47.16
TrackSunTrustRH 89.33 11/6/2006 Outperform NS $44.90 +43.56% -16.98% +60.54
TrackBreanMurray 89.84 10/6/2006 Outperform NS $41.64 +19.36% +3.18% +16.18 11/27/2006 @ $49.70
TrackJimCramer < 20 4/7/2006 Outperform 3W $37.17 +92.22% +18.03% +74.19 9/28/2007 @ $71.45

Featured Broker Partners